Health Care & Life Sciences » Pharmaceuticals | InDex Pharmaceuticals Holding AB

InDex Pharmaceuticals Holding AB

InDex Pharmaceuticals Holding AB
Stock Exchange First North Sweden
EPS
SEK1.29
Market Cap
SEK405.18 M
Shares Outstanding
62.53 M
Public Float
22.17 M

Profile

Address
Tomtebodavägen 23 A
Stockholm AB 171 77
Sweden
Employees -
Website http://www.indexpharma.com
Updated 09/14/2018
InDex Pharmaceuticals Holding AB discovers and develops drugs for the treatment of diseases such as inflammation and cancer. It conducts research, technology development, and commercialization of scientific discoveries in the biomedical field. The firm also develops a platform of patent-protected substances, so-called deoxyribonucleic acid-based ImmunModulatory Sequences, with the potential to be used for the treatment of various immunological diseases.

Financials

View All

Wenche Nelly A. Rolfsen Sandsborg
Chairman
Uli Alf Hacksell
Independent Director